Answers are grounded in this paper and cite their sources.
Intensity of stromal changes could serve as an independent prognostic factor in the assessment of biochemical recurrence-free survival. Among prostate cancer patients with an identical Gleason score, it could identify patients with a higher risk of biochemical recurrence. Thus, stromal changes and their intensity could serve as a novel marker for the recognition of patients with an increased risk of disease recurrence.
No takes yet. Share an insight, caveat, or question.
Tomas et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: